13F filer · CIK 946431 ↗
Swedbank AB
You are looking at Q4 2023. See the latest, Q3 2026 →
Reported value
$62.11B
+7.6% on the quarter before
Positions
700
25 new · 29 sold out
Top 10
32.3%
of the value
Est. gain
+$6.22B
on stocks held all quarter
Est. return
+12.1%
on those stocks since Q3 2023
Positions as of Dec 31, 2023, from Swedbank AB's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 49% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2023. Striped tiles are options.
Largest buys
Since Q3 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom~$1.07BAdded · 2.1% → 4.4%+956,589 shares
- Microsoft~$257.8MAdded · 6.7% → 7.8%+685,538 shares
- Amazon~$230.2MAdded · 2.0% → 2.5%+1,515,247 shares
- Veralto Corp~$211.4MNew · 0.0% → 0.3%+2,569,751 shares
- Alphabet~$156.1MAdded · 2.1% → 2.4%+1,117,822 shares
- Nvidia~$120.6MAdded · 3.7% → 4.1%+243,565 shares
- Prologis~$94.2MAdded · 0.8% → 1.0%+706,720 shares
- Solaredge Technologies Inc~$91.9MAdded · 0.7% → 0.6%+981,856 shares
- The Cigna Group~$91.2MAdded · 0.3% → 0.5%+304,402 shares
- Mcdonalds Corp~$85.0MAdded · 0.4% → 0.6%+286,558 shares
Largest sells
Since Q3 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- ApplePUT~$2.66BCut · 4.4% → 0.3%−13,750,000 underlying
- Vmware Inc~$1.67BSold out · 2.9% → 0.0%−10,023,660 shares
- TeslaPUT~$275.2MSold out · 0.5% → 0.0%−1,100,000 underlying
- Activision Blizzard Inc~$162.1MSold out · 0.3% → 0.0%−1,730,844 shares
- Centene Corp Del~$108.9MCut · 1.6% → 1.5%−1,467,415 shares
- Horizon Therapeutics Pub L~$89.8MSold out · 0.2% → 0.0%−776,494 shares
- Cisco~$64.5MCut · 1.7% → 1.4%−1,276,286 shares
- Apple~$52.7MCut · 4.1% → 4.2%−273,696 shares
- Synopsys~$33.7MCut · 1.6% → 1.6%−65,465 shares
- Mckesson Corp~$33.2MCut · 1.0% → 0.9%−71,729 shares
Holdings
As of Dec 31, 2023. Changes are in shares against Sep 30, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +5.6% · price +19.1% | 7.8% | $4.86B | +$737.2M | ||||||||
| BroadcomCOM · shares +65% · price +34.4% | 4.4% | $2.71B | +$419.8M | ||||||||
| AppleCOM · shares −2.0% · price +12.5% | 4.2% | $2.61B | +$288.9M | ||||||||
| NvidiaCOM · shares +5.0% · price +13.8% | 4.1% | $2.54B | +$294.8M | ||||||||
| AmazonCOM · shares +17% · price +19.5% | 2.5% | $1.58B | +$220.9M | ||||||||
| AlphabetCAP STK CL A · shares +12% · price +6.7% | 2.4% | $1.47B | +$83.0M | ||||||||
| AlphabetCAP STK CL C · shares +2.5% · price +6.9% | 2.1% | $1.32B | +$82.9M | ||||||||
| SynopsysCOM · shares −3.2% · price +12.2% | 1.6% | $1.01B | +$109.4M | ||||||||
| Unitedhealth Group IncCOM · shares +0.3% · price +4.4% | 1.6% | $995.0M | +$42.0M | ||||||||
| MetaCL A · shares +7.4% · price +17.9% | 1.6% | $969.8M | +$137.2M | ||||||||
| AdobeCOM · shares +4.1% · price +17.0% | 1.5% | $949.6M | +$132.5M | ||||||||
| Centene Corp DelCOM · shares −11% · price +7.7% | 1.5% | $911.8M | +$65.5M | ||||||||
| Accenture Plc IrelandSHS CLASS A · shares −1.2% · price +14.3% | 1.4% | $865.6M | +$108.0M | ||||||||
| CiscoCOM · shares −7.0% · price −6.0% | 1.4% | $852.9M | −$54.7M | ||||||||
| ServiceNowCOM · shares +1.7% · price +26.4% | 1.3% | $832.4M | +$170.9M | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +0.6% · price +1.8% | 1.1% | $713.7M | +$12.6M | ||||||||
| Danaher CorporationCOM · shares +3.4% · price −6.8% | 1.1% | $693.4M | −$48.6M | ||||||||
| Eli LillyCOM · shares +6.8% · price +8.5% | 1.1% | $671.7M | +$49.4M | ||||||||
| KeysightCOM · shares +2.6% · price +20.2% | 1.0% | $641.9M | +$105.3M | ||||||||
| Thermo Fisher Scientific IncCOM · shares −0.4% · price +4.9% | 1.0% | $640.1M | +$29.7M | ||||||||
| Jpmorgan Chase & CoCOM · shares +2.4% · price +17.3% | 1.0% | $631.4M | +$90.9M | ||||||||
| PrologisCOM · shares +18% · price +18.8% | 1.0% | $627.4M | +$84.4M | ||||||||
| Merck & Co IncCOM · shares +13% · price +5.9% | 0.95% | $590.7M | +$29.2M | ||||||||
| Applied MaterialsCOM · shares −2.7% · price +17.1% | 0.94% | $586.2M | +$85.4M | ||||||||
| MastercardCL A · shares −0.3% · price +7.7% | 0.93% | $577.9M | +$41.5M | ||||||||
| Total · 700 positions | 100% | $62.11B | +$6.22B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2023 to Q4 2023: 673 stocks held throughout, up $6.22B (+12.1%).
- Microsoft+$737.2M+19%
- Broadcom+$419.8M+34%
- Nvidia+$294.8M+14%
- Apple+$288.9M+12%
- Amazon+$220.9M+20%
- Hasbro Inc−$20.9M−23%
- Pfizer Inc−$26.1M−13%
- Danaher Corporation−$48.6M−7%
- Cisco−$54.7M−6%
- Solaredge Technologies Inc−$118.2M−28%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 27, 2026 | $117.74B+2% | SEC ↗ |
| Q2 2026 | Jul 15, 2026 | $115.99B+22% | SEC ↗ |
| Q1 2026 | Apr 29, 2026 | $95.15B−8% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 (amended) | $103.37B+5% | SEC ↗ |
| Q3 2025 | Oct 15, 2025 | $98.65B+11% | SEC ↗ |
| Q2 2025 | Jul 10, 2025 | $88.96B+9% | SEC ↗ |
| Q4 2024 | Jan 22, 2025 | $81.32B+4% | SEC ↗ |
| Q3 2024 | Oct 11, 2024 (amended) | $78.51B+5% | SEC ↗ |
| Q2 2024 | Jul 11, 2024 | $74.81B+6% | SEC ↗ |
| Q1 2024 | May 13, 2024 (amended) | $70.85B+14% | SEC ↗ |
| Q4 2023 | Dec 6, 2024 | $62.11B+8% | SEC ↗ |
| Q3 2023 | Dec 6, 2024 | $57.73B−2% | SEC ↗ |
| Q2 2023 | Dec 6, 2024 | $58.98B+16% | SEC ↗ |
| Q1 2023 | Dec 6, 2024 | $50.71B+12% | SEC ↗ |
| Q4 2022 | Dec 6, 2024 | $45.47B+8% | SEC ↗ |
| Q3 2022 | Dec 6, 2024 | $42.13B−5% | SEC ↗ |
| Q2 2022 | Dec 6, 2024 | $44.30B−18% | SEC ↗ |
| Q1 2022 | Dec 6, 2024 | $53.93B−10% | SEC ↗ |
| Q4 2021 | Dec 6, 2024 | $59.82B+12% | SEC ↗ |
| Q3 2021 | Dec 6, 2024 | $53.56B+0% | SEC ↗ |
| Q2 2021 | Dec 6, 2024 | $53.31B+11% | SEC ↗ |
| Q1 2021 | Dec 6, 2024 | $48.14B | SEC ↗ |